Literature DB >> 3551149

How to recognize and treat parathyroid carcinoma.

Y Fujimoto, T Obara.   

Abstract

Parathyroid carcinoma is a rare tumor and its clinical course is variable. Differentiation of patients with parathyroid carcinoma from those with parathyroid adenoma is often difficult both preoperatively and at operation. For good results, the surgeon must recognize this disorder and perform an en bloc resection at the initial surgery. A neck dissection is necessary only when there is evidence of regional node metastases. After surgery, periodic follow-up of the serum calcium and iPTH levels is essential. When hypercalcemia recurs or the serum iPTH increases, localization studies with the use of thallium-201 scanning help detect local recurrence and regional lymph node metastases, but unfortunately, this method often fails to localize pulmonary metastases. Chest radiographs and CT scanning are useful for delineating pulmonary metastases. A wide excision of locally recurrent tumor, an en bloc radical neck dissection and mediastinum dissection for lymphatic metastases, and an aggressive surgical resection of lung metastases are recommended. Although these operations are rarely curative, they usually offer definite palliation of the marked hypercalcemia, often for a considerable period. Drugs to lower the serum calcium level and systemic chemotherapy are currently of only limited benefit, and radiation therapy is generally ineffective.

Entities:  

Mesh:

Year:  1987        PMID: 3551149     DOI: 10.1016/s0039-6109(16)44188-5

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  22 in total

1.  Lymph node involvement and surgical approach in parathyroid cancer.

Authors:  Klaus-Martin Schulte; Nadia Talat; John Miell; Caje Moniz; Prakash Sinha; Salvador Diaz-Cano
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Risk factors of thyroid cancer in Babol, Northern Iran.

Authors:  Zoleika Moazezi; Mahmoud Mahmoudi; Yousef Yahyahpour; Alireza Alaleh
Journal:  Caspian J Intern Med       Date:  2011

3.  Severe Hyperparathyroidism Versus Parathyroid Carcinoma: A clinical dilemma.

Authors:  Mariam Al-Fadhli; Suhail A R Doi; Thomas Muttikkal; Basel Al-Sumait
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

4.  Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology.

Authors:  Gaurav Agarwal; Kaushal K Prasad; Dilip K Kar; Narendra Krishnani; Rakesh Pandey; Saroj K Mishra
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 5.  Parathyroid carcinoma: case report.

Authors:  G Sturniolo; E Gagliano; A Tonante; F Taranto; E Papalia; R Cascio; C Damiano; F Vermiglio; G Sturniolo
Journal:  G Chir       Date:  2013 May-Jun

6.  Results of iterative surgery for persistent and recurrent parathyroid carcinoma.

Authors:  Maurizio Iacobone; Cesare Ruffolo; Franco Lumachi; Gennaro Favia
Journal:  Langenbecks Arch Surg       Date:  2005-06-03       Impact factor: 3.445

Review 7.  Mid-mediastinal parathyroid lesions: preoperative localization and surgical approach in two cases.

Authors:  T Obara; Y Fujimoto; R Tanaka; Y Ito; T Kodama; T Yashiro; Y Kanaji; T Yamashita; A Fukuuchi
Journal:  Jpn J Surg       Date:  1990-07

Review 8.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

Review 9.  Parathyroid carcinoma: etiology, diagnosis, and treatment.

Authors:  Takahiro Okamoto; Masatoshi Iihara; Takao Obara; Toshihiko Tsukada
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 10.  Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.

Authors:  T Obara; Y Fujimoto
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.